Myriad Genetics, Inc. (MYGN)

Myriad Genetics Statistics

Total Valuation

MYGN has a market cap or net worth of $1.39 billion. The enterprise value is $1.44 billion.

Market Cap	1.39B
Enterprise Value	1.44B

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

MYGN has 91.04 million shares outstanding. The number of shares has increased by 9.79% in one year.

Current Share Class	91.04M
Shares Outstanding	91.04M
Shares Change (YoY)	+9.79%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	2.21%
Owned by Institutions (%)	94.91%
Float	83.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	146.41
PS Ratio	1.66
Forward PS	1.56
PB Ratio	1.90
P/TBV Ratio	10.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.09

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.20.

Current Ratio	1.90
Quick Ratio	1.46
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.80

Financial Efficiency

Return on equity (ROE) is -16.39% and return on invested capital (ROIC) is -6.78%.

Return on Equity (ROE)	-16.39%
Return on Assets (ROA)	-5.35%
Return on Capital (ROIC)	-6.78%
Revenue Per Employee	$305,037
Profits Per Employee	-$42,963
Employee Count	2,700
Asset Turnover	0.74
Inventory Turnover	9.91

Taxes

Income Tax	-700,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.38% in the last 52 weeks. The beta is 1.94, so MYGN's price volatility has been higher than the market average.

Beta (5Y)	1.94
52-Week Price Change	-14.38%
50-Day Moving Average	22.73
200-Day Moving Average	23.49
Relative Strength Index (RSI)	19.49
Average Volume (20 Days)	1,062,302

Short Selling Information

The latest short interest is 4.48 million, so 4.92% of the outstanding shares have been sold short.

Short Interest	4.48M
Short Previous Month	4.49M
Short % of Shares Out	4.92%
Short % of Float	5.35%
Short Ratio (days to cover)	7.93

Income Statement

In the last 12 months, MYGN had revenue of $823.60 million and -$116.00 million in losses. Loss per share was -$1.30.

Revenue	823.60M
Gross Profit	569.50M
Operating Income	-95.40M
Pretax Income	-156.60M
Net Income	-116.00M
EBITDA	-33.90M
EBIT	-95.40M
Loss Per Share	-$1.30

Balance Sheet

The company has $99.90 million in cash and $143.10 million in debt, giving a net cash position of -$43.20 million or -$0.47 per share.

Cash & Cash Equivalents	99.90M
Total Debt	143.10M
Net Cash	-43.20M
Net Cash Per Share	-$0.47
Equity (Book Value)	731.70M
Book Value Per Share	8.04
Working Capital	138.90M

Cash Flow

In the last 12 months, operating cash flow was -$70.00 million and capital expenditures -$25.40 million, giving a free cash flow of -$95.40 million.

Operating Cash Flow	-70.00M
Capital Expenditures	-25.40M
Free Cash Flow	-95.40M
FCF Per Share	-$1.05

Margins

Gross margin is 69.15%, with operating and profit margins of -11.58% and -14.08%.

Gross Margin	69.15%
Operating Margin	-11.58%
Pretax Margin	-14.17%
Profit Margin	-14.08%
EBITDA Margin	-4.12%
EBIT Margin	-11.58%
FCF Margin	-17.61%

Dividends & Yields

MYGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.79%
Shareholder Yield	-9.79%
Earnings Yield	-8.33%
FCF Yield	-6.85%

Analyst Forecast

The average price target for MYGN is $26.64, which is 74.12% higher than the current price. The consensus rating is "Buy".

Price Target	$26.64
Price Target Difference	74.12%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	7.51%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.

Last Split Date	Mar 26, 2009
Split Type	Forward
Split Ratio	2:1

Scores

MYGN has an Altman Z-Score of 3.07 and a Piotroski F-Score of 4.

Altman Z-Score	3.07
Piotroski F-Score	4